ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,802.82
      -0.67%
      US Tech 100
      20,337.60
      -1.08%
      Dow Jones
      41,603.07
      -0.61%
      Brent Oil
      64.525
      0.00%
      Bitcoin
      107,783.67
      0.44%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ENDRA Life Sciences Inc (NDRA)

      7. ENDRA Life Sciences Inc (NDRA) News

      NDRA

      ENDRA Life Sciences (NDRA)

      ENDRA Life Sciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NDRA
      DateTimeSourceHeadlineSymbolCompany
      05/15/20254:05PMBusiness WireENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial ResultsNASDAQ:NDRAENDRA Life Sciences Inc
      04/02/20254:36PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NDRAENDRA Life Sciences Inc
      03/31/20258:51AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NDRAENDRA Life Sciences Inc
      03/31/20258:49AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      03/31/20258:05AMBusiness WireENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 TherapiesNASDAQ:NDRAENDRA Life Sciences Inc
      03/31/20258:00AMBusiness WireENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
      02/14/20255:04PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NDRAENDRA Life Sciences Inc
      11/22/20248:42AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      11/22/20248:00AMBusiness WireENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:NDRAENDRA Life Sciences Inc
      11/21/20245:14PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:NDRAENDRA Life Sciences Inc
      11/19/20245:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
      11/15/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      11/15/20244:01PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:NDRAENDRA Life Sciences Inc
      11/15/20249:24AMBusiness WireENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
      11/12/20248:00AMBusiness WireStudy Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024NASDAQ:NDRAENDRA Life Sciences Inc
      11/06/20248:00AMBusiness WireENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European PatentNASDAQ:NDRAENDRA Life Sciences Inc
      11/05/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      10/29/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      10/22/20248:00AMBusiness WireENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in GermanyNASDAQ:NDRAENDRA Life Sciences Inc
      09/16/20245:28PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
      09/06/20244:33PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
      08/28/20245:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      08/28/20244:17PMBusiness WireENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NDRAENDRA Life Sciences Inc
      08/23/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      08/22/20244:14PMBusiness WireENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
      08/16/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
      08/16/20248:00AMBusiness WireENDRA Life Sciences Announces Reverse Stock SplitNASDAQ:NDRAENDRA Life Sciences Inc
      08/15/20245:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NDRAENDRA Life Sciences Inc
      08/14/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
      08/13/20244:05PMBusiness WireENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024NASDAQ:NDRAENDRA Life Sciences Inc
       Showing the most relevant articles for your search:NASDAQ:NDRA